Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | MT-CO2 | P00403 | 4/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.35 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6764758 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL7109157 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL28883906 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL30456186 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL3477839 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL7139457 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL7706359 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL3721835 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL535669 | 1.00 | KMT2A (0.50) | KMT2ACA1CA2CA4MT-CO2 | |
| SCHEMBL3438194 | 0.97 | CA1 (0.48) | KMT2ACA1CA2CA4MT-CO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391597-B1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2018-08-22 | — | — | EP | disclosed |
| US-8188320-B2 | Process for preparing pure cyclododecanone | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | CCNA1, CYC1, CCNA2 | KMT2A 2011/4885CA1 472/4885CA2 1158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.